Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group

Division of Cardiovascular Medicine, Stanford University Medical Center, California 94305.

Patients with pulmonary hypertension are at risk of developing fatal right heart failure after heart transplantation. To evaluate this risk potential, candidates for heart transplantation are screened by measuring rest right heart pressures and the response to nitroprusside. To test the validity of this approach, the influence of pretransplantation right heart catheterization data on outcome after transplantation was analyzed in 293 of 301 consecutive patients. Patients with a pulmonary vascular resistance greater than 2.5 Wood units measured at baseline study had a 3-month mortality rate of 17.9% compared with 6.9% in patients with resistance less than or equal to 2.5 units (p less than 0.02). Patients with a pulmonary vascular resistance greater than 2.5 units at baseline study could be differentiated further according to their hemodynamic response to nitroprusside; those whose resistance could be reduced to less than or equal to 2.5 units with a stable systemic systolic pressure greater than or equal to 85 mm Hg had a 3-month mortality rate of only 3.8%. In contrast, patients whose pulmonary vascular resistance could not be reduced to less than 2.5 units, and those whose resistance could be reduced to less than or equal to 2.5 units but only at the expense of systemic hypotension (systolic pressure less than or equal to 85 mm Hg) had a 3-month mortality rate of 40.6% and 27.5%, respectively. Furthermore, all 10 patients who died of right heart failure belonged to the latter two groups.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				G. D. Lewis, R. Shah, K. Shahzad, J. M. Camuso, P. P. Pappagianopoulos, J. Hung, A. Tawakol, R. E. Gerszten, D. M. Systrom, K. D. Bloch, et al. Sildenafil Improves Exercise Capacity and Quality of Life in Patients With Systolic Heart Failure and Secondary Pulmonary Hypertension Circulation, October 2, 2007; 116(14): 1555 - 1562. [Abstract] [Full Text] [PDF]

				C. D. Etz, H. A. Welp, T. D.T. Tjan, A. Hoffmeier, E. Weigang, H. H. Scheld, and C. Schmid Medically Refractory Pulmonary Hypertension: Treatment With Nonpulsatile Left Ventricular Assist Devices Ann. Thorac. Surg., May 1, 2007; 83(5): 1697 - 1705. [Abstract] [Full Text] [PDF]

				D. Zimpfer, P. Zrunek, S. Sandner, H. Schima, M. Grimm, A. Zuckermann, E. Wolner, and G. Wieselthaler Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 698 - 702. [Abstract] [Full Text] [PDF]

				D. Zimpfer, P. Zrunek, W. Roethy, M. Czerny, H. Schima, L. Huber, M. Grimm, A. Rajek, E. Wolner, and G. Wieselthaler Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 689 - 695. [Abstract] [Full Text] [PDF]

				S. Klotz, F. Wenzelburger, J. Stypmann, H. Welp, G. Drees, C. Schmid, and H. H. Scheld Reversible Pulmonary Hypertension in Heart Transplant Candidates: To Transplant or Not to Transplant Ann. Thorac. Surg., November 1, 2006; 82(5): 1770 - 1773. [Abstract] [Full Text] [PDF]

				C. A. Anderson, S. K Shernan, M. Leacche, J. D. Rawn, S. Paul, T. Mihaljevic, J. A. Jarcho, L. W. Stevenson, J. C.-T. Fang, E. F. Lewis, et al. Severity of Intraoperative Tricuspid Regurgitation Predicts Poor Late Survival Following Cardiac Transplantation Ann. Thorac. Surg., November 1, 2004; 78(5): 1635 - 1642. [Abstract] [Full Text] [PDF]

				J. Martin, M. P. Siegenthaler, O. Friesewinkel, T. Fader, A. van de Loo, G. Trummer, M. Berchtold-Herz, and F. Beyersdorf Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation--a preliminary study Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 971 - 977. [Abstract] [Full Text] [PDF]

				B. K. Gehlbach and E. Geppert The Pulmonary Manifestations of Left Heart Failure Chest, February 1, 2004; 125(2): 669 - 682. [Abstract] [Full Text] [PDF]

				H. K. Eltzschig, T. Mihaljevic, J. G. Byrne, R. Ehlers, B. Smith, and S. K. Shernan Echocardiographic evidence of right ventricular remodeling after transplantation Ann. Thorac. Surg., August 1, 2002; 74(2): 584 - 586. [Abstract] [Full Text] [PDF]

				B. Stobierska-Dzierzek, H. Awad, and R. E. Michler The evolving management of acute right-sided heart failure in cardiac transplant recipients J. Am. Coll. Cardiol., October 1, 2001; 38(4): 923 - 931. [Abstract] [Full Text] [PDF]

				J. A. Elefteriades, C. J. Lovoulos, G. Tellides, L. J. Goldstein, E. J. Rocco, S. G. Condos, and G. S. Kopf Right ventricle-sparing heart transplant: promising new technique for recipients with pulmonary hypertension Ann. Thorac. Surg., June 1, 2000; 69(6): 1858 - 1863. [Abstract] [Full Text] [PDF]

				J. Butler, D. B. Chomsky, and J. R. Wilson Pulmonary hypertension and exercise intolerance in patients with heart failure J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1802 - 1806. [Abstract] [Full Text] [PDF]

				H. S. Mueller, K. Chatterjee, K. B. Davis, M. A. Fifer, C. Franklin, M. A. Greenberg, A. J. Labovitz, P. K. Shah, K. J. Tuman, M. H. Weil, et al. Present use of bedside right heart catheterization in patients with cardiac disease J. Am. Coll. Cardiol., September 1, 1998; 32(3): 840 - 864. [Full Text] [PDF]

				S. A. Hunt and O.H. Frazier Mechanical Circulatory Support and Cardiac Transplantation Circulation, May 26, 1998; 97(20): 2079 - 2090. [Full Text] [PDF]

				G. A Deuchar, M. N Hicks, S. M Cobbe, C. C Docherty, and M. R MacLean Pulmonary responses to 5-hydroxytryptamine and endothelin-1 in a rabbit model of left ventricular dysfunction Cardiovasc Res, May 1, 1998; 38(2): 500 - 507. [Abstract] [Full Text] [PDF]

				J. M. Chen, H. R. Levin, R. E. Michler, C. J. Prusmack, E. A. Rose, and K. D. Aaronson REEVALUATING THE SIGNIFICANCE OF PULMONARY HYPERTENSION BEFORE CARDIAC TRANSPLANTATION: DETERMINATION OF OPTIMAL THRESHOLDS AND QUANTIFICATION OF THE EFFECT OF REVERSIBILITY ON PERIOPERATIVE MORTALITY J. Thorac. Cardiovasc. Surg., October 1, 1997; 114(4): 627 - 634. [Abstract] [Full Text]

				K. D. Aaronson, J. S. Schwartz, T.-M. Chen, K.-L. Wong, J. E. Goin, and D. M. Mancini Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation Circulation, June 17, 1997; 95(12): 2660 - 2667. [Abstract] [Full Text]